Immunoprecise Antibodies Ltd IPA

Healthcare Biotechnology

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.

NDAQ:IPA - Post by User

Immunoprecise Antibodies Ltd > Gap filling exercise now on.

<< Previous

Bullboard Posts

Next >>

Comment by cleareyeon Nov 11, 2021 10:31am

131 Views

Post# 34114708

RE:Gap filling exercise now on.

On Sept 29, I thought that we were heading down to fill that gap which means dipping to C$6.94.

That is still on the table.

I'll be happier about buying more once that gap is filled.

cleareye.

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?